BRIVGARD 50MG TAB

Description

Brivgard 50 mg Tablet is formulated with Brivaracetam, a novel antiepileptic drug belonging to the racetam class. It is primarily prescribed for the management of partial-onset seizures in individuals aged 4 years and older. Brivaracetam exhibits a high affinity for the synaptic vesicle protein 2A (SV2A) in the brain, which plays a crucial role in modulating neurotransmitter release. By binding to SV2A, Brivaracetam helps stabilize neuronal activity, thereby reducing the frequency and severity of seizures.

Key Features:

• Active Ingredient: Brivaracetam 50 mg

• Indications: Management of partial-onset seizures in epilepsy

• Mechanism of Action: Binds to SV2A protein, modulating neurotransmitter release and stabilizing neuronal activity

• Dosage: Typically administered orally once or twice daily, with or without food. The exact dosage should be determined by a healthcare professional based on individual patient needs.

• Common Side Effects: Drowsiness, dizziness, fatigue, nausea, vomiting, behavioral changes such as agitation or aggression.

• Precautions: Use with caution in patients with hepatic impairment. Not recommended for use during pregnancy or breastfeeding unless clearly needed. Monitor for mood changes or suicidal thoughts.

Brivgard 50 mg Tablet offers a targeted approach to seizure management, providing patients with a treatment option that has a favorable safety profile and is generally well-tolerated. As with all antiepileptic medications, it is essential to adhere to the prescribed regimen and consult a healthcare provider for any concerns or side effects.